HIGHLIGHTS
- who: Wei Tian et al. from the Department Oncology III, Zibo Central Hospital, Shandong University, Zibo, Shandong, Peoples` Shandong, People` have published the research: Fluoropyrimidine combination therapy versus fluoropyrimidine monotherapy for gemcitabine-refractory advanced pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials, in the Journal: PLOS ONE of February/13,/2023
- how: The authors collected all phase II-III and prospective randomized controlled trials. Dichotomous data were compared using risk ratio (RR).
SUMMARY
Pancreatic cancer is associated with a poor prognosis and the seventh leading cause of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.